2 Stocks We Like and 1 Blockbuster Drug Problem

Before you go, we thought you'd like these...
Before you go close icon

The following video is part of our nationally syndicated Motley Fool Money radio show, in which host Chris Hill and advisors Ron Gross, James Early, and Seth Jayson discuss the week's business and investing news. In this segment, the guys examine the future of the prescription-drug industry and analyze the retail sector in search of stocks they like.

Looking for stocks that we like? Look no further than The Motley Fool's latest new report, "The Motley Fool's Top Stock for 2012," which highlights a company that's revolutionizing commerce in Latin America. You can get instant access to the name of this company by clicking here -- it's free.

At the time this article was published Chris Hillowns shares of Pfizer. The Motley Fool owns shares of Aeropostale.Motley Fool newsletter serviceshave recommended buying shares of Pfizer and Cato. Try any of our Foolish newsletter servicesfree for 30 days. We Fools don't all hold the same opinions, but we all believe thatconsidering a diverse range of insightsmakes us better investors. The Motley Fool has adisclosure policy.

Copyright © 1995 - 2011 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Read Full Story

Want more news like this?

Sign up for Finance Report by AOL and get everything from business news to personal finance tips delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.

From Our Partners